ELIZABETH SCHOLL: Open Payments
NPI 1972605301 · CARROLLTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,423 in 64 payments from 23 companies in 2025. Trend: 2023 $1,583 · 2024 $1,834 · 2025 $1,423
Food & beverage: $1,423
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $248 |
| Novo Nordisk Inc | 7 | $152 |
| Phathom Pharmaceuticals, Inc. | 2 | $140 |
| PFIZER INC. | 8 | $140 |
| Insmed, Inc. | 5 | $124 |
| Grifols USA, LLC | 3 | $81 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $60 |
| Lilly USA, LLC | 3 | $55 |
| AstraZeneca Pharmaceuticals LP | 3 | $50 |
| Sumitomo Pharma America, Inc. | 3 | $49 |
Products named: OFEV, VOQUEZNA, ELIQUIS, Arikayce, Prolastin-C Liquid, Ozempic, GLASSIA, JARDIANCE.
Industry payments across GA — which companies pay providers there.
